Drug Delivery Business12d
Tandem Diabetes Care introduces next-gen automated insulin delivery algorithm
Tandem Diabetes Care announced today that it launched its next-generation Control-IQ+ automated insulin delivery algorithm in ...
Drug Delivery Business12d
Tandem has positive data for automated insulin delivery in type 2 diabetes population
Tandem Diabetes Care (Nasdaq:TNDM) today announced positive data supporting its automated insulin delivery technology for ...
Morningstar13d
Tandem Diabetes Care Launches New Control-IQ+ Automated Insulin Delivery Technology in the United States
– Enhanced features extend automated insulin delivery (AID) to people ages 2 years and older with type 1 diabetes and adults with type 2 diabetes – Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a ...
Tandem Diabetes launches new Control-IQ+ technology
Tandem Diabetes (TNDM) announced the United States commercial launch of Control-IQ+ technology, the latest generation of the company’s advanced ...